📰 Anders Rylander News
Page 5 - Anders Rylander News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anders Rylander. Real-time updates on events, politics, business and more.
August 15, 2022
UPPSALA, SE / ACCESSWIRE / August 15, 2022 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)Biovica, active in cancer diagnostics, is hosting a market update due DiviTum®TKa's US market approval
July 30, 2022
30.07.2022 - UPPSALA, SWEDEN / ACCESSWIRE / July 30, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II).Biovica, active in cancer diagnostics, today announces that FDA has granted 510(k) clearance for the product DiviTum®TKa as an aid in ...
July 30, 2022
UPPSALA, SWEDEN / ACCESSWIRE / July 30, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II).Biovica, active in cancer diagnostics, today announces that FDA has granted 510(k) clearance for
July 27, 2022
UPPSALA, SWEDEN / ACCESSWIRE / July 27, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby
June 16, 2022
UPPSALA, SWEDEN / ACCESSWIRE / June 16, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)SEK thousandsQ4 21/22Q4 20/21May-April 21/22May-April 20/21Net sales1,0823182,0452,077Operating
May 9, 2022
UPPSALA, SWEDEN / ACCESSWIRE / May 9, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica, active in cancer diagnostics, today announces that the company's blood test DiviTum®TKa
April 28, 2022
UPPSALA, SE / ACCESSWIRE / April 28, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica, active in cancer diagnostics, today announces that the company has submitted its updated
April 28, 2022
UPPSALA, SWEDEN / ACCESSWIRE / April 28, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica, active in cancer diagnostics, will host a Capital Markets Day on Tuesday May 17, 2022
April 28, 2022
28.04.2022 - UPPSALA, SE / ACCESSWIRE / April 28, 2022 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II)Biovica, active in cancer diagnostics, today announces that the company has submitted its updated 510(k)-application to the U.S. Food and Drug ...
March 22, 2022
UPPSALA, SWEDEN / ACCESSWIRE / March 22, 2022 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)Biovica, active in cancer diagnostics, today announced that positive results on CDK 4/6 standard